ellenrx

ITP (Immune Thrombocytopenia)

Affects approximately 3.3 per 100,000 adults annually in the U.S.·4 treatments

Immune thrombocytopenia (ITP) is an autoimmune condition where the body's immune system destroys its own platelets, leading to dangerously low platelet counts and increased bleeding risk. Symptoms range from easy bruising and petechiae to life-threatening hemorrhage. Treatment aims to raise platelet counts to safe levels.

You may qualify for clinical trials that provide Promacta at no cost

Clinical trials may give you access to this treatment while helping advance medical research

Search Trials
PromactaoralGamunex-CivigPrivigenivigRituxaninfusion

First-line treatment is typically corticosteroids (prednisone or dexamethasone). IVIG is used for rapid platelet elevation in acute situations. For chronic ITP failing corticosteroids, thrombopoietin receptor agonists (Promacta, Nplate) are standard second-line therapy. Rituximab is used off-label but may face coverage challenges.

Platelet count above insurer's threshold for treatment (often <30,000/µL)

Very Common

Must fail corticosteroids before IVIG or TPO-RA

Common

Rituximab denied — not FDA-approved for ITP (off-label use)

Common

Promacta/Nplate denied without prior corticosteroid and IVIG failure

Occasional

Insufficient documentation of bleeding symptoms or risk

Occasional

  1. 1.Document platelet counts, bleeding history, and impact on daily activities
  2. 2.Include corticosteroid trial history with dates, doses, and reasons for failure or intolerance
  3. 3.For urgent IVIG requests, document active bleeding or platelet count requiring immediate intervention
  4. 4.For rituximab appeals, cite ASH guidelines supporting rituximab for refractory ITP
  5. 5.Include specialist (hematologist) recommendation and rationale

Active clinical trials that may provide treatment at no cost.

Copay cards, patient assistance programs, and foundation grants for this condition's treatments.

Want to know what you'll actually pay?

Estimate your annual out-of-pocket cost with and without assistance programs.

Estimate My Costs

Denied for ITP (Immune Thrombocytopenia) Treatment?

Ellen can decode your denial, find your appeal strategy, and generate your appeal letter — free.

Decode My DenialEstimate My Costs

Related Conditions

Lupus / SLEKawasaki Disease